KALV / KalVista Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

KalVista Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US4834971032

Actions en circulation 50,339,823 shares
Actions d'initiés30 241 864 shares
Participation des initiés60,08 %
Nombre total d'initiés61
Indice de confiance des initiés

L'indice de confiance des initiés identifie les entreprises achetées par les initiés.

Il est le résultat d'un modèle quantitatif sophistiqué et multifactoriel qui identifie les entreprises présentant les niveaux les plus élevés de capitalisation d'initiés. Le modèle de notation utilise une combinaison du nombre net d'initiés ayant acheté des actions au cours des 90 derniers jours, du nombre total d'actions achetées en pourcentage du flottant et du nombre total d'actions détenues par les initiés. Le nombre varie de 0 à 100, les chiffres les plus élevés indiquant un niveau d'accumulation supérieur à celui de ses pairs, et 50 étant la moyenne.

Fréquence de mise à jour : Quotidienne

Voir Les meilleurs choix des initiés, qui fournit une liste des entreprises ayant la plus forte accumulation d'initiés.

Indice de confiance des dirigeants

L'indice de confiance des dirigeants identifie les entreprises dont les actions sont achetées par des dirigeants d'entreprise.

Par définition, les dirigeants d'entreprise sont des initiés, mais contrairement à d'autres initiés (actionnaires à 10 % et membres du conseil d'administration), les dirigeants travaillent quotidiennement pour l'entreprise et utilisent leur propre argent lorsqu'ils effectuent des opérations (les actionnaires à 10 % et les membres du conseil d'administration sont souvent des gestionnaires de fonds qui gèrent l'argent d'autrui). À ce titre, les opérations d'initiés réalisées par les dirigeants sont beaucoup plus significatives et doivent être traitées de manière appropriée.

Comme l'indice de confiance des initiés, l'indice de confiance des dirigeants est le résultat d'un modèle quantitatif sophistiqué et multifactoriel qui identifie les entreprises présentant les niveaux les plus élevés d'accumulation de dirigeants.

Fréquence de mise à jour : Quotidienne

Consultez la section Les meilleurs choix des initiés, qui fournit une liste des entreprises dont le sentiment des initiés est le plus élevé.

Principaux indicateurs des initiés

Cette carte montre comment l'entreprise se positionne par rapport à divers indicateurs d'initiés. La position en centile montre comment cette entreprise se situe par rapport aux autres entreprises sur les marchés américains. Une position plus élevée indique une meilleure situation.

Par exemple, il est généralement admis que les achats d'initiés sont un indicateur positif, de sorte que les entreprises dont les achats d'initiés sont plus nombreux se positionnent mieux que celles dont les achats d'initiés sont moins nombreux (ou même les ventes d'initiés).

Nombre net d'achats d'initiés (position)

-4 ( )

10872 out of 11305

Le nombre net d'initiés achetant est le nombre total d'initiés achetant moins le nombre total d'initiés vendant au cours des 90 derniers jours. La position en centile est indiquée ici (de 0 à 100%).

Pourcentage du flottant acheté par les initiés (position)

-0.371 %( )

10879 out of 11224

Le pourcentage du flottant acheté par les initiés est le nombre total d'actions achetées par les initiés moins le nombre total d'actions vendues par les initiés au cours des 90 derniers jours, divisé par le flottant total et multiplié par 100.

Graphique des opérations d'initiés

Les opérations d'initiés de KalVista Pharmaceuticals, Inc. sont présentées dans le graphique suivant. Les initiés sont des dirigeants, des administrateurs ou des investisseurs importants dans une entreprise. En général, il est illégal pour les initiés d'effectuer des opérations d'initiés dans leur entreprise sur la base d'informations matérielles non publiques. Cela ne signifie pas qu'il est illégal pour eux d'effectuer toute transaction dans leurs propres entreprises. Toutefois, ils doivent déclarer toutes les transactions à la SEC au moyen d'un formulaire 4.

Liste d'initiés et indicateurs de rentabilité

Ce tableau présente la liste des initiés connus et est généré automatiquement à partir des dépôts communiqués à la SEC. Outre les noms, le titre le plus récent et la désignation du directeur, du dirigeant ou du propriétaire à 10 %, nous indiquons les dernières participations divulguées. En outre, lorsque cela est possible, nous indiquons les performances historiques des opérations d'initiés. La performance historique des transactions est une moyenne pondérée de la performance des opérations d'achat réelles sur le marché public effectuées par l'initié. Pour plus d'informations sur le mode de calcul, regardez ce webinaire sur YouTube.

See our leaderboard of most profitable insider traders.

Initié Profit moyen (%) Actions
détenues
Fractionnement
Ajusté
Acmp Iv Llc 10% Owner - [10%] 4 343 550 4 343 550
Acp Iv, L.p. 10% Owner - [10%] 4 343 550 4 343 550
Richard Aldrich Director - [D] 934 484 934 484
Audhya Paul K. CHIEF MEDICAL OFFICER - [O] 122 505 122 505
Steven L Basta Director - [D] 0 0
Albert Cha Director - [D] 0 0
Bruce A Cleveland 10% Owner - [10%] 4 619 196 4 619 196
David M Clapper 29 000
Thomas Andrew Crockett CEO, Director - [D] [O] 211 203 211 203
Martin Edwards Director - [D] 0 0
Feener Edward P. CHIEF SCIENTIFIC OFFICER - [O] 72 858 72 858
Philip T Gianos 10% Owner - [10%] 4 619 196 4 619 196
Gravett David M. 100 000
W Stephen Holmes 10% Owner - [10%] 4 619 196 4 619 196
InterWest Management Partners IX, LLC 10% Owner - [10%] 4 619 196 4 619 196
InterWest Partners IX, LP 10% Owner - [10%] 4 619 196 4 619 196
Daniel Janney 10% Owner - [10%] 4 343 550 4 343 550
Keith Katkin 29 000
Nina S Kjellson 10% Owner - [10%] 4 619 196 4 619 196
Gilbert H Kliman 10% Owner - [10%] 4 619 196 4 619 196
Initié Profit moyen (%) Actions
détenues
Fractionnement
Ajusté
Bong Y Koh 10% Owner - [10%] 1 544 112 5 303 985
Peter Kolchinsky 10% Owner - [10%] 1 441 070 1 441 070
Hayley Lewis 33 181
Andreas Maetzel Senior Vice President, Medical - [O] 0 0
Marcee Maroney VP, Clinical Affairs - [O] 0 0
John McKune 10 000
Khaled Nasr 10% Owner - [10%] 4 619 196 4 619 196
Guy P Nohra Director - [D] 4 343 550 4 343 550
A/S Novo 10% Owner - [10%] 0 0
Arnold L Oronsky 10% Owner - [10%] 388 766 388 766
Benjamin L Palleiko CHIEF EXECUTIVE OFFICER, Director - [D] [O] 386 858 386 858
Douglas A Pepper 10% Owner - [10%] 4 619 196 4 619 196
Brian JG Pereira Director - [D] 0 0
Ra Capital Management, Llc Director, 10% Owner - [D] [10%] 1 441 070 1 441 070
RA Capital Healthcare Fund LP 10% Owner - [10%] 591 070 591 070
Premchandran Ramiya 60 586
David Renzi President & CEO, Director - [D] [O] 0 0
Joshua Resnick Director - [D] 71 211 71 211
Daniel B Soland Director - [D] 10 000 10 000
Sv Life Sciences Fund Iv Strategic Partners, L. P. 10% Owner - [10%] 47 471 47 471
Initié Profit moyen (%) Actions
détenues
Fractionnement
Ajusté
Sv Life Sciences Fund Iv, L.p. 10% Owner - [10%] 47 471 47 471
SV Life Sciences Fund IV (GP), L.P. 10% Owner - [10%] 47 471 47 471
Svlsf Iv, Llc 10% Owner - [10%] 47 471 47 471
David Joseph Saul 56 000
Nimish P Shah 10% Owner - [10%] 1 544 112 5 303 985
Shah Rajeev M. Director, 10% Owner - [D] [10%] 1 441 070 1 441 070
Michael David Smith Senior VP, Development - [O] 0 0
Nicole Sweeny Chief Commercial Officer - [O] 32 291 32 291
Patrick Treanor 17 000
Edward W Unkart 10 000
VHCP Co-Investment Holdings II, LLC 10% Owner - [10%] 1 544 112 1 544 112
VHCP Co-Investment Holdings III, LLC 10% Owner - [10%] 1 544 112 5 303 985
VHCP Management II, LLC 10% Owner - [10%] 1 544 112 1 544 112
VHCP Management III, LLC 10% Owner - [10%] 1 544 112 5 303 985
Vivo Ventures Vi Affiilates Fund, L.p. 10% Owner - [10%] 4 204 562 4 204 562
Venrock Healthcare Capital Partners II, L.P. 10% Owner - [10%] 1 544 112 1 544 112
Venrock Healthcare Capital Partners III, L.P. 10% Owner - [10%] 5 303 985 5 303 985
Vivo Ventures Fund VI, L.P. 10% Owner - [10%] 4 204 562 4 204 562
Vivo Ventures VI, LLC 10% Owner - [10%] 4 204 562 4 204 562
Christopher Yea CHIEF DEVELOPMENT OFFICER - [O] 132 052 132 052
Reza Zadno 15 750

Report errors via our new Insider Auditing Tool

Historique des achats d'initiés - Analyse des bénéfices à court terme

Dans cette section, nous analysons la rentabilité de chaque achat d'initié non planifié et effectué sur le marché public dans KALV / KalVista Pharmaceuticals, Inc.. Cette analyse permet de comprendre si l'initié génère régulièrement des rendements anormaux et s'il vaut la peine d'être suivi. Cette analyse porte sur l'année qui suit chaque transaction et les résultats sont théoriques .

Le tableau suivant présente les achats sur le marché public les plus récents qui ne faisaient pas partie d'un plan de trading automatique.

Date de la transaction Initiés Actions
déclarées
Prix
déclaré
Actions
ajustées
Prix
ajusté
Base de coût Jours jusqu'au
Max
Prix au
Max
Bénéfice
Max ($)
Rendement maximal (%)
2025-04-09 Venrock Healthcare Capital Partners III, L.P. 25 000 9,4200 25 000 9,4200 235 500 99 16.0100 164 750 69,96
2025-02-13 Venrock Healthcare Capital Partners III, L.P. 61 700 9,3300 61 700 9,3300 575 661
2025-02-12 Venrock Healthcare Capital Partners III, L.P. 100 000 9,2300 100 000 9,2300 923 000
2025-02-11 Venrock Healthcare Capital Partners III, L.P. 26 703 9,1800 26 703 9,1800 245 134
2025-02-10 Venrock Healthcare Capital Partners III, L.P. 4 137 9,1400 4 137 9,1400 37 812
2025-02-07 Venrock Healthcare Capital Partners III, L.P. 73 649 9,2900 73 649 9,2900 684 199
2025-02-03 Venrock Healthcare Capital Partners III, L.P. 14 562 9,2200 14 562 9,2200 134 262
2025-01-31 Venrock Healthcare Capital Partners III, L.P. 11 754 8,8900 11 754 8,8900 104 493
2025-01-30 Venrock Healthcare Capital Partners III, L.P. 43 707 8,7600 43 707 8,7600 382 873

Prix ajusté est le prix ajusté suite au fractionnement. Actions ajustées est le nombre d'actions ajustées suite au fractionnement.

KALV / KalVista Pharmaceuticals, Inc. Insider Trades
Historique des ventes d'initiés - Analyse des pertes à court terme

Dans cette section, nous analysons l'évitement des pertes à court terme de chaque vente d'initié non planifiée et réalisée sur le marché public dans KALV / KalVista Pharmaceuticals, Inc.. Un schéma cohérent d'évitement des pertes peut suggérer que les transactions de vente futures peuvent prédire des baisses de prix. Cette analyse porte sur l'année qui suit chaque transaction, et les résultats sont théoriques .

Le tableau suivant présente les ventes les plus récentes sur le marché public qui ne faisaient pas partie d'un plan de trading automatique.

Date de la transaction Initiés Actions
déclarées
Prix
déclaré
Actions
ajustées
Prix
ajusté
Base de coût Jours jusqu'au
Min
Prix au
Min
Perte maximale
évitée ($)
Perte maximale
évitée (%)
2025-08-25 Sweeny Nicole 1 480 13,4200 1 480 13,4200 19 862 0 12.9900 -636 -3,20
2025-08-25 Audhya Paul K. 2 336 13,4200 2 336 13,4200 31 349
2025-08-25 Yea Christopher 1 954 13,4200 1 954 13,4200 26 223
2025-08-22 Palleiko Benjamin L 10 940 13,2228 10 940 13,2228 144 657
2025-08-22 Audhya Paul K. 2 942 13,2228 2 942 13,2228 38 901
2025-08-22 Yea Christopher 2 362 13,2228 2 362 13,2228 31 232
2025-08-22 Sweeny Nicole 1 864 13,2228 1 864 13,2228 24 647
2025-08-18 Yea Christopher 2 649 13,1870 2 649 13,1870 34 932
2025-08-18 Palleiko Benjamin L 4 409 13,1870 4 409 13,1870 58 141

Prix ajusté est le prix ajusté suite au fractionnement. Actions ajustées est le nombre d'actions ajustées suite au fractionnement.

KALV / KalVista Pharmaceuticals, Inc. Insider Trades
Historique des transactions

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Date
de dépôt
Date
de transaction
Formulaire Initié Libellé Nom du titre Code 10b5-1 Direct Prix
d'exercice
Prix
unitaire
Unités
Modifié
Valeur
Modifiée (1K)
Options
restantes
Actions
restantes
2025-08-26 2025-08-25 4 Sweeny Nicole KALV Common Stock S - Sale D 13,4200 -1 480 -20 32 291
2025-08-26 2025-08-22 4 Sweeny Nicole KALV Common Stock M - Exercise D 5 000 33 771
2025-08-26 2025-08-25 4 Yea Christopher KALV Common Stock S - Sale D 13,4200 -1 954 -26 132 052
2025-08-26 2025-08-22 4 Yea Christopher KALV Common Stock M - Exercise D 3 125 134 006
2025-08-26 2025-08-25 4 Audhya Paul K. KALV Common Stock S - Sale D 13,4200 -2 336 -31 122 505
2025-08-26 2025-08-22 4 Audhya Paul K. KALV Common Stock M - Exercise D 5 000 124 841
2025-08-25 2025-08-22 4 Sweeny Nicole KALV Common Stock S - Sale D 13,2228 -1 864 -25 28 771
2025-08-25 2025-08-21 4 Sweeny Nicole KALV Common Stock M - Exercise D 6 250 30 635
2025-08-25 2025-08-22 4 Yea Christopher KALV Common Stock S - Sale D 13,2228 -2 362 -31 130 881
2025-08-25 2025-08-21 4 Yea Christopher KALV Common Stock M - Exercise D 3 750 133 243
2025-08-25 2025-08-22 4 Audhya Paul K. KALV Common Stock S - Sale D 13,2228 -2 942 -39 119 841
2025-08-25 2025-08-21 4 Audhya Paul K. KALV Common Stock M - Exercise D 6 250 122 783
2025-08-25 2025-08-22 4 Palleiko Benjamin L KALV Common Stock S - Sale D 13,2228 -10 940 -145 386 858
2025-08-25 2025-08-21 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 23 250 397 798
2025-08-19 2025-08-18 4 Yea Christopher KALV Common Stock S - Sale D 13,1870 -2 649 -35 129 493
2025-08-19 2025-08-17 4 Yea Christopher KALV Common Stock M - Exercise D 4 203 132 142
2025-08-19 2025-08-18 4 Audhya Paul K. KALV Common Stock S - Sale D 13,1870 -2 939 -39 116 533
2025-08-19 2025-08-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 6 446 119 472
2025-08-19 2025-08-18 4 Palleiko Benjamin L KALV Common Stock S - Sale D 13,1870 -4 409 -58 374 548
2025-08-19 2025-08-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 9 362 378 957
2025-07-10 2025-07-09 4 Palleiko Benjamin L KALV Common Stock S - Sale D 15,6925 -32 979 -518 369 595
2025-07-10 2025-07-08 4 Palleiko Benjamin L KALV Common Stock A - Award D 87 500 402 574
2025-07-10 2025-07-09 4 Yea Christopher KALV Common Stock S - Sale D 15,6925 -30 250 -475 127 939
2025-07-10 2025-07-08 4 Yea Christopher KALV Common Stock A - Award D 60 000 158 189
2025-06-10 2025-06-09 4 Palleiko Benjamin L KALV Common Stock S - Sale D 14,5000 -7 169 -104 315 074
2025-06-10 2025-06-06 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 15 625 322 243
2025-05-27 2025-05-23 4 Audhya Paul K. KALV Common Stock S - Sale D 11,3102 -2 146 -24 113 026
2025-05-27 2025-05-22 4 Audhya Paul K. KALV Common Stock M - Exercise D 5 000 115 172
2025-05-27 2025-05-23 4 Yea Christopher KALV Common Stock S - Sale D 11,3093 -1 926 -22 98 189
2025-05-27 2025-05-22 4 Yea Christopher KALV Common Stock M - Exercise D 3 125 100 115
2025-05-23 2025-05-22 4 Audhya Paul K. KALV Common Stock S - Sale D 11,8755 -2 689 -32 110 172
2025-05-23 2025-05-21 4 Audhya Paul K. KALV Common Stock M - Exercise D 6 250 112 861
2025-05-23 2025-05-22 4 Yea Christopher KALV Common Stock S - Sale D 11,8755 -2 317 -28 96 990
2025-05-23 2025-05-21 4 Yea Christopher KALV Common Stock M - Exercise D 3 750 99 307
2025-05-23 2025-05-22 4 Palleiko Benjamin L KALV Common Stock S - Sale D 11,8755 -9 999 -119 306 618
2025-05-23 2025-05-21 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 23 250 316 617
2025-05-20 2025-05-19 4 Palleiko Benjamin L KALV Common Stock S - Sale D 11,8428 -3 808 -45 293 367
2025-05-20 2025-05-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 9 364 297 175
2025-05-20 2025-05-19 4 Yea Christopher KALV Common Stock S - Sale D 11,8428 -2 600 -31 95 557
2025-05-20 2025-05-17 4 Yea Christopher KALV Common Stock M - Exercise D 4 205 98 157
2025-05-20 2025-05-19 4 Audhya Paul K. KALV Common Stock S - Sale D 11,8428 -2 776 -33 106 611
2025-05-20 2025-05-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 6 447 109 387
2025-04-11 2025-04-09 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 9,4200 25 000 236 5 303 985
2025-03-10 2025-03-07 4 Palleiko Benjamin L KALV Common Stock S - Sale D 11,9700 -6 669 -80 287 811
2025-03-10 2025-03-06 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 15 625 294 480
2025-02-25 2025-02-24 4 Audhya Paul K. KALV Common Stock S - Sale D 10,0200 -2 394 -24 102 940
2025-02-25 2025-02-22 4 Audhya Paul K. KALV Common Stock M - Exercise D 5 000 105 334
2025-02-25 2025-02-24 4 Yea Christopher KALV Common Stock S - Sale D 10,0200 -1 918 -19 93 952
2025-02-25 2025-02-22 4 Yea Christopher KALV Common Stock M - Exercise D 3 125 95 870
2025-02-19 2025-02-18 4 Audhya Paul K. KALV Common Stock S - Sale D 9,8242 -3 125 -31 100 334
2025-02-19 2025-02-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 6 447 103 459
2025-02-19 2025-02-18 4 Yea Christopher KALV Common Stock S - Sale D 9,8242 -2 601 -26 92 745
2025-02-19 2025-02-17 4 Yea Christopher KALV Common Stock M - Exercise D 4 204 95 346
2025-02-19 2025-02-18 4 Palleiko Benjamin L KALV Common Stock S - Sale D 9,8242 -5 104 -50 278 855
2025-02-19 2025-02-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 9 363 283 959
2025-02-14 2025-02-13 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 9,3300 61 700 576 5 278 985
2025-02-14 2025-02-12 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 9,2300 100 000 923 5 217 285
2025-02-11 2025-02-11 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 9,1800 26 703 245 5 117 285
2025-02-11 2025-02-10 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 9,1400 4 137 38 5 090 582
2025-02-11 2025-02-07 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 9,2900 73 649 684 5 086 445
2025-02-03 2025-02-03 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 9,2200 14 562 134 5 012 796
2025-02-03 2025-01-31 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 8,8900 11 754 104 4 998 234
2025-02-03 2025-01-30 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 8,7600 43 707 383 4 986 480
2025-02-03 3 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock I 4 942 773
2024-12-09 2024-12-09 4 Palleiko Benjamin L KALV Common Stock S - Sale D 9,7500 -7 627 -74 274 596
2024-12-09 2024-12-06 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 15 625 282 223
2024-11-27 2024-11-26 4 Audhya Paul K. KALV Common Stock S - Sale D 9,8702 -2 187 -22 97 012
2024-11-27 2024-11-22 4 Audhya Paul K. KALV Common Stock M - Exercise D 5 000 99 199
2024-11-27 2024-11-26 4 Yea Christopher KALV Common Stock S - Sale D 9,8718 -1 963 -19 91 142
2024-11-27 2024-11-22 4 Yea Christopher KALV Common Stock M - Exercise D 3 125 93 105
2024-11-19 2024-11-18 4 Palleiko Benjamin L KALV Common Stock S - Sale D 9,2565 -14 400 -133 266 598
2024-11-19 2024-11-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 30 198 280 998
2024-11-19 2024-11-18 4 Yea Christopher KALV Common Stock S - Sale D 9,2565 -7 192 -67 89 980
2024-11-19 2024-11-17 4 Yea Christopher KALV Common Stock M - Exercise D 11 496 97 172
2024-11-19 2024-11-18 4 Audhya Paul K. KALV Common Stock S - Sale D 9,2566 -8 077 -75 94 199
2024-11-19 2024-11-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 18 531 102 276
2024-09-10 2024-09-09 4 Palleiko Benjamin L KALV Common Stock S - Sale D 12,1901 -7 352 -90 250 800
2024-09-10 2024-09-06 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 15 625 258 152
2024-08-26 2024-08-23 4 Audhya Paul K. KALV Common Stock S - Sale D 12,4000 -2 135 -26 83 745
2024-08-26 2024-08-22 4 Audhya Paul K. KALV Common Stock M - Exercise D 5 000 85 880
2024-08-26 2024-08-23 4 Yea Christopher KALV Common Stock S - Sale D 12,4000 -1 916 -24 85 676
2024-08-26 2024-08-22 4 Yea Christopher KALV Common Stock M - Exercise D 3 125 87 592
2024-08-21 2024-08-19 4 Palleiko Benjamin L KALV Common Stock S - Sale D 12,0133 -14 215 -171 242 527
2024-08-21 2024-08-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 30 195 256 742
2024-08-21 2024-08-19 4 Audhya Paul K. KALV Common Stock S - Sale D 12,0133 -7 973 -96 80 880
2024-08-21 2024-08-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 18 528 88 853
2024-08-21 2024-08-19 4 Yea Christopher KALV Common Stock S - Sale D 12,0133 -7 102 -85 84 467
2024-08-21 2024-08-17 4 Yea Christopher KALV Common Stock M - Exercise D 11 495 91 569
2024-06-10 2024-06-07 4 Palleiko Benjamin L KALV Common Stock S - Sale D 11,5296 -7 465 -86 224 547
2024-06-10 2024-06-06 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 15 625 232 012
2024-05-21 2024-05-20 4 Feener Edward P. KALV Common Stock S - Sale D 11,7645 -8 088 -95 72 858
2024-05-21 2024-05-17 4 Feener Edward P. KALV Common Stock M - Exercise D 18 789 80 946
2024-05-21 2024-05-20 4 Audhya Paul K. KALV Common Stock S - Sale D 11,7645 -13 175 -155 70 325
2024-05-21 2024-05-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 30 614 83 500
2024-05-21 2024-05-20 4 Palleiko Benjamin L KALV Common Stock S - Sale D 11,7645 -21 959 -258 216 387
2024-05-21 2024-05-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 51 031 238 346
2024-05-21 2024-05-20 4 Yea Christopher KALV Common Stock S - Sale D 11,7645 -11 610 -137 80 074
2024-05-21 2024-05-17 4 Yea Christopher KALV Common Stock M - Exercise D 18 789 91 684
2024-02-21 2024-02-20 4 Feener Edward P. KALV Common Stock S - Sale D 14,7200 -300 -4 62 157
2024-02-21 2024-02-20 4 Feener Edward P. KALV Common Stock S - Sale D 14,0366 -19 591 -275 62 457
2024-02-21 2024-02-20 4 Feener Edward P. KALV Common Stock S - Sale D 14,1148 -8 397 -119 82 048
2024-02-21 2024-02-17 4 Feener Edward P. KALV Common Stock M - Exercise D 18 788 90 445
2024-02-21 2024-02-20 4 Yea Christopher KALV Common Stock S - Sale D 14,1147 -12 053 -170 72 895
2024-02-21 2024-02-17 4 Yea Christopher KALV Common Stock M - Exercise D 18 788 84 948
2024-02-21 2024-02-20 4 Palleiko Benjamin L KALV Common Stock S - Sale D 14,1148 -22 802 -322 187 315
2024-02-21 2024-02-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 51 029 210 117
2024-02-21 2024-02-20 4 Audhya Paul K. KALV Common Stock S - Sale D 14,1150 -14 295 -202 52 886
2024-02-21 2024-02-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 30 613 67 181
2024-02-21 2024-02-20 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 14,1148 -24 888 -351 211 203
2024-02-21 2024-02-17 4 Crockett Thomas Andrew KALV Common Stock M - Exercise D 54 415 236 091
2024-02-16 2024-02-14 4 Palleiko Benjamin L KALV Common Stock S - Sale D 15,0093 -40 855 -613 159 088
2024-02-16 2024-02-14 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 15,0093 -58 356 -876 181 676
2024-02-16 2024-02-14 4 Feener Edward P. KALV Common Stock S - Sale D 15,0093 -28 171 -423 71 657
2024-02-16 2024-02-14 4 Yea Christopher KALV Common Stock S - Sale D 15,0093 -39 886 -599 66 160
2024-02-13 2024-02-11 4 Palleiko Benjamin L KALV Common Stock A - Award D 87 500 199 943
2024-02-13 2024-02-11 4 Feener Edward P. KALV Common Stock A - Award D 60 000 99 828
2024-02-13 2024-02-11 4 Yea Christopher KALV Common Stock A - Award D 60 000 106 046
2024-02-13 2024-02-11 4 Crockett Thomas Andrew KALV Common Stock A - Award D 122 500 240 032
2024-02-08 2024-02-08 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 14,7000 29 747 437 4 824 731
2024-02-08 2024-02-07 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 14,5600 51 827 755 4 794 984
2024-02-08 2024-02-06 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 14,7400 4 474 66 4 743 157
2024-02-05 2024-02-01 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 16,8143 -700 -12 117 532
2024-02-05 2024-02-01 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 16,1751 -9 300 -150 118 232
2024-02-01 2024-01-30 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 14,4700 88 099 1 275 4 738 683
2024-01-29 2024-01-29 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 14,2200 80 600 1 146 4 650 584
2024-01-29 2024-01-26 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,9800 4 174 54 4 569 984
2024-01-29 2024-01-25 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,7300 7 030 89 4 565 810
2024-01-24 2024-01-24 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,4400 20 686 257 4 558 780
2024-01-24 2024-01-23 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,5400 10 897 137 4 538 094
2024-01-24 2024-01-22 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,5500 67 546 848 4 527 197
2024-01-19 2024-01-19 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,4300 25 000 311 4 459 651
2024-01-19 2024-01-18 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,5100 39 680 496 4 434 651
2024-01-19 2024-01-17 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,6000 78 925 994 4 394 971
2024-01-16 2024-01-16 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,7300 19 599 249 4 316 046
2024-01-16 2024-01-11 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,6800 6 647 84 4 296 447
2024-01-12 2024-01-11 4 Feener Edward P. KALV Common Stock S - Sale D 13,0303 -22 679 -296 39 828
2024-01-10 2024-01-10 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,6700 47 700 604 4 289 800
2024-01-10 2024-01-09 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,5600 20 816 261 4 242 100
2024-01-10 2024-01-08 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,4400 69 184 861 4 221 284
2024-01-10 2024-01-09 4 Feener Edward P. KALV Common Stock S - Sale D 13,0000 -100 -1 62 507
2024-01-10 2024-01-08 4 Feener Edward P. KALV Common Stock S - Sale D 13,0074 -17 221 -224 62 607
2024-01-05 2024-01-04 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,1100 41 764 506 4 152 100
2024-01-05 2024-01-03 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,2000 17 605 215 4 110 336
2023-12-29 2023-12-29 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,4900 6 013 75 4 092 731
2023-12-29 2023-12-28 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,5000 471 490 5 894 4 086 718
2023-12-29 2023-12-27 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 11,9700 41 514 497 3 615 228
2023-12-28 2023-12-27 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 12,0151 -30 000 -360 127 532
2023-12-28 3 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock I 3 573 714
2023-11-21 2023-11-20 4 Palleiko Benjamin L KALV Common Stock S - Sale D 8,2293 -13 008 -107 112 443
2023-11-21 2023-11-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 30 197 125 451
2023-11-21 2023-11-20 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 8,2293 -14 807 -122 157 532
2023-11-21 2023-11-17 4 Crockett Thomas Andrew KALV Common Stock M - Exercise D 33 583 172 339
2023-11-21 2023-11-20 4 Yea Christopher KALV Common Stock S - Sale D 8,2293 -7 113 -59 46 046
2023-11-21 2023-11-17 4 Yea Christopher KALV Common Stock M - Exercise D 11 497 53 159
2023-11-21 2023-11-20 4 Feener Edward P. KALV Common Stock S - Sale D 8,2293 -4 958 -41 79 828
2023-11-21 2023-11-17 4 Feener Edward P. KALV Common Stock M - Exercise D 11 497 84 786
2023-11-21 2023-11-20 4 Audhya Paul K. KALV Common Stock S - Sale D 8,2293 -7 985 -66 36 568
2023-11-21 2023-11-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 18 530 44 553
2023-11-01 2023-10-30 4 Crockett Thomas Andrew KALV Common Stock G - Gift D -8 000 138 756
2023-09-13 2023-09-11 4 CHA ALBERT KALV Common Stock S - Sale D 10,5028 -18 000 -189 0
2023-09-13 2023-09-11 4 CHA ALBERT KALV Common Stock M - Exercise D 7,8800 12 000 95 18 000
2023-09-13 2023-09-11 4 CHA ALBERT KALV Common Stock M - Exercise D 6,7100 6 000 40 6 000
2023-08-21 2023-08-18 4 Audhya Paul K. KALV Common Stock S - Sale D 10,7288 -8 020 -86 26 023
2023-08-21 2023-08-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 18 529 34 043
2023-08-21 2023-08-18 4 Feener Edward P. KALV Common Stock S - Sale D 10,7287 -4 976 -53 73 289
2023-08-21 2023-08-17 4 Feener Edward P. KALV Common Stock M - Exercise D 11 494 78 265
2023-08-21 2023-08-18 4 Yea Christopher KALV Common Stock S - Sale D 10,7287 -7 142 -77 41 662
2023-08-21 2023-08-17 4 Yea Christopher KALV Common Stock M - Exercise D 11 494 48 804
2023-08-21 2023-08-18 4 Palleiko Benjamin L KALV Common Stock S - Sale D 10,7287 -13 067 -140 95 254
2023-08-21 2023-08-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 30 195 108 321
2023-08-21 2023-08-18 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 10,7288 -14 876 -160 146 756
2023-08-21 2023-08-17 4 Crockett Thomas Andrew KALV Common Stock M - Exercise D 33 582 161 632
2023-05-19 2023-05-18 4 Palleiko Benjamin L KALV Common Stock S - Sale D 10,1444 -4 037 -41 78 126
2023-05-19 2023-05-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 9 364 82 163
2023-05-19 2023-05-18 4 Yea Christopher KALV Common Stock S - Sale D 10,1444 -2 604 -26 37 310
2023-05-19 2023-05-17 4 Yea Christopher KALV Common Stock M - Exercise D 4 205 39 914
2023-05-19 2023-05-18 4 Feener Edward P. KALV Common Stock S - Sale D 10,1444 -1 786 -18 66 771
2023-05-19 2023-05-17 4 Feener Edward P. KALV Common Stock M - Exercise D 4 205 68 557
2023-05-19 2023-05-18 4 Audhya Paul K. KALV Common Stock S - Sale D 10,1444 -2 780 -28 13 014
2023-05-19 2023-05-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 6 447 15 794
2023-05-19 2023-05-18 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 10,1444 -5 627 -57 128 050
2023-05-19 2023-05-17 4 Crockett Thomas Andrew KALV Common Stock M - Exercise D 12 750 133 677
2023-02-23 2023-02-17 4 Palleiko Benjamin L KALV Common Stock S - Sale D 7,6600 -4 954 -38 72 799
2023-02-23 2023-02-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 9 363 77 753
2023-02-23 2023-02-17 4 Yea Christopher KALV Common Stock S - Sale D 7,6600 -2 727 -21 35 709
2023-02-23 2023-02-17 4 Yea Christopher KALV Common Stock M - Exercise D 4 204 38 436
2023-02-23 2023-02-17 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 7,6600 -6 700 -51 120 927
2023-02-23 2023-02-17 4 Crockett Thomas Andrew KALV Common Stock M - Exercise D 12 749 127 627
2023-02-23 2023-02-17 4 Feener Edward P. KALV Common Stock S - Sale D 7,6600 -2 228 -17 64 352
2023-02-23 2023-02-17 4 Feener Edward P. KALV Common Stock M - Exercise D 4 204 66 580
2023-02-23 2023-02-17 4 Audhya Paul K. KALV Common Stock S - Sale D 7,6600 -3 412 -26 9 347
2023-02-23 2023-02-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 6 446 6 313
2022-11-21 2022-11-18 4 Yea Christopher KALV Common Stock S - Sale D 5,4400 -1 139 -6 34 232
2022-11-21 2022-11-17 4 Yea Christopher KALV Common Stock M - Exercise D 1 774 35 371
2022-11-21 2022-11-18 4 Palleiko Benjamin L KALV Common Stock S - Sale D 5,4400 -722 -4 68 390
2022-11-21 2022-11-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 2 419 69 112
2022-11-21 2022-11-18 4 Feener Edward P. KALV Common Stock S - Sale D 5,4400 -530 -3 62 376
2022-11-21 2022-11-17 4 Feener Edward P. KALV Common Stock M - Exercise D 1 774 62 906
2022-11-21 2022-11-18 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 5,4400 -1 785 -10 114 878
2022-11-21 2022-11-17 4 Crockett Thomas Andrew KALV Common Stock M - Exercise D 5 805 116 663
2022-11-21 2022-11-18 4 Audhya Paul K. KALV Common Stock S - Sale D 5,4400 -722 -4 5 946
2022-11-21 2022-11-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 2 419 6 668
2022-09-07 2022-09-02 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 17,0134 -1 320 -22 110 858
2022-09-07 2022-07-02 4 Crockett Thomas Andrew KALV Common Stock G - Gift D -6 500 112 178
2022-08-19 2022-08-17 4 Audhya Paul K. KALV Common Stock S - Sale D 14,9615 -725 -11 1 693
2022-08-19 2022-08-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 2 418 2 418
2022-08-19 2022-08-17 4 Yea Christopher KALV Common Stock S - Sale D 14,9607 -1 145 -17 33 597
2022-08-19 2022-08-17 4 Yea Christopher KALV Common Stock M - Exercise D 1 773 34 742
2022-08-19 2022-08-17 4 Feener Edward P. KALV Common Stock S - Sale D 14,9619 -532 -8 61 132
2022-08-19 2022-08-17 4 Feener Edward P. KALV Common Stock M - Exercise D 1 773 61 664
2022-08-19 2022-08-17 4 Palleiko Benjamin L KALV Common Stock S - Sale D 14,9608 -725 -11 66 693
2022-08-19 2022-08-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 2 418 67 418
2022-08-19 2022-08-17 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 14,9641 -1 797 -27 112 178
2022-08-19 2022-08-17 4 Crockett Thomas Andrew KALV Common Stock M - Exercise D 5 805 113 975
2022-05-27 2022-05-26 4 Treanor Patrick KALV Stock Option (right to buy) A - Award D 8,60 17 000 17 000
2022-05-19 2022-05-17 4 Audhya Paul K. KALV Restricted Stock Units A - Award D 38 700 38 700
2022-05-19 2022-05-17 4 Audhya Paul K. KALV Employee Stock Option (Right to Buy) A - Award D 9,28 25 800 25 800
2022-05-19 2022-05-17 4 Feener Edward P. KALV Restricted Stock Units A - Award D 28 380 28 380
2022-05-19 2022-05-17 4 Feener Edward P. KALV Employee Stock Option (Right to Buy) A - Award D 9,28 18 920 18 920
2022-05-19 2022-05-17 4 Yea Christopher KALV Restricted Stock Units A - Award D 28 380 28 380
2022-05-19 2022-05-17 4 Yea Christopher KALV Employee Stock Option (Right to Buy) A - Award D 9,28 18 920 18 920
2022-05-19 2022-05-17 4 Smith Michael David KALV Restricted Stock Units A - Award D 15 480 15 480
2022-05-19 2022-05-17 4 Smith Michael David KALV Employee Stock Option (Right to Buy) A - Award D 9,28 10 320 10 320
2022-05-19 2022-05-17 4 Crockett Thomas Andrew KALV Restricted Stock Units A - Award D 92 880 92 880
2022-05-19 2022-05-17 4 Crockett Thomas Andrew KALV Employee Stock Option (Right to Buy) A - Award D 9,28 61 920 61 920
2022-05-19 2022-05-17 4 Palleiko Benjamin L KALV Restricted Stock Units A - Award D 38 700 38 700
2022-05-19 2022-05-17 4 Palleiko Benjamin L KALV Employee Stock Option (Right to Buy) A - Award D 9,28 25 800 25 800
2022-03-11 2022-03-09 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 17,0693 -10 000 -171 114 670
2022-01-11 2022-01-07 4 Feener Edward P. KALV Employee Stock Option (right to buy) M - Exercise D 8,21 -23 857 27 943
2022-01-11 2022-01-07 4 Feener Edward P. KALV Employee Stock Option (right to buy) M - Exercise D 7,07 -33 800 0
2022-01-11 2022-01-07 4 Feener Edward P. KALV Common Stock M - Exercise D 8,2100 23 857 196 59 891
2022-01-11 2022-01-07 4 Feener Edward P. KALV Common Stock M - Exercise D 7,0700 33 800 239 36 034
2021-11-03 2021-11-01 4 Feener Edward P. KALV Common Stock S - Sale D 18,0706 -6 000 -108 2 234
2021-11-03 2021-11-01 4 Yea Christopher KALV Common Stock S - Sale D 18,0656 -5 000 -90 32 969
2021-10-04 2021-10-01 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 17,1841 -10 000 -172 124 670
2021-10-04 2021-09-30 4 Edwards Martin KALV Director Stock Option (Right to Buy) A - Award D 17,45 10 000 10 000
2021-10-01 2021-09-30 4 Unkart Edward W KALV Director Stock Option (Right to Buy) A - Award D 17,45 10 000 10 000
2021-10-01 2021-09-30 4 SOLAND DANIEL B KALV Director Stock Option (Right to Buy) A - Award D 17,45 10 000 10 000
2021-10-01 2021-09-30 4 Pereira Brian JG KALV Director Stock Option (Right to Buy) A - Award D 17,45 10 000 10 000
2021-10-01 2021-09-30 4 CHA ALBERT KALV Director Stock Option (Right to Buy) A - Award D 17,45 10 000 10 000
2021-08-04 2021-08-02 4 Yea Christopher KALV Common Stock S - Sale D 20,5157 -5 000 -103 37 969
2021-08-04 2021-08-02 4 Feener Edward P. KALV Common Stock S - Sale D 20,5223 -6 000 -123 8 234
2021-07-02 2021-07-01 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 24,3548 -5 650 -138 134 670
2021-07-02 2021-07-01 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 23,8787 -4 350 -104 140 320
2021-06-22 2021-06-17 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 30,0380 -1 067 -32 144 670
2021-06-11 2021-06-09 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 30,0549 -8 933 -268 145 737
2021-06-03 2021-06-01 4 Smith Michael David KALV Stock Option (right to buy) M - Exercise D 8,39 -7 500 22 596
2021-06-03 2021-06-01 4 Smith Michael David KALV Common Stock S - Sale D 26,8295 -7 500 -201 0
2021-06-03 2021-06-01 4 Smith Michael David KALV Common Stock M - Exercise D 8,3900 7 500 63 7 500
2021-06-03 2021-06-02 4 Feener Edward P. KALV Common Stock S - Sale D 27,0461 -1 062 -29 14 234
2021-06-03 2021-06-02 4 Feener Edward P. KALV Common Stock S - Sale D 26,3341 -7 138 -188 15 296
2021-06-03 2021-06-01 4 Feener Edward P. KALV Common Stock S - Sale D 27,2111 -14 -0 22 434
2021-06-03 2021-06-01 4 Feener Edward P. KALV Common Stock S - Sale D 26,8085 -25 786 -691 22 448
2021-05-28 2021-05-26 4 Smith Michael David KALV Employee Stock Option (Right to Buy) A - Award D 25,95 35 000 35 000
2021-05-28 2021-05-26 4 Feener Edward P. KALV Employee Stock Option (Right to Buy) A - Award D 25,95 60 000 60 000
2021-05-28 2021-05-26 4 Yea Christopher KALV Employee Stock Option (Right to Buy) A - Award D 25,95 60 000 60 000
2021-05-28 2021-05-26 4 Palleiko Benjamin L KALV Employee Stock Option (Right to Buy) A - Award D 25,95 75 000 75 000
2021-05-28 2021-05-26 4 Crockett Thomas Andrew KALV Employee Stock Option (Right to Buy) A - Award D 25,95 200 000 200 000
2021-05-28 2021-04-29 4 Crockett Thomas Andrew KALV Common Stock G - Gift D -4 750 154 670
2021-05-28 2021-05-26 4 Maetzel Andreas KALV Employee Stock Option (Right to Buy) A - Award D 25,95 25 000 25 000
2021-05-07 2021-05-03 4/A Feener Edward P. KALV Common Stock S - Sale D 24,8418 -6 000 -149 48 234
2021-05-06 2021-05-03 4 Yea Christopher KALV Common Stock S - Sale D 24,8393 -5 000 -124 42 969
2021-05-06 2021-05-03 4 Feener Edward P. KALV Employee Stock Option (right to buy) M - Exercise D 10,21 -6 000 20 255
2021-05-06 2021-05-03 4 Feener Edward P. KALV Common Stock S - Sale D 24,8418 -6 000 -149 54 234
2021-05-06 2021-05-03 4 Feener Edward P. KALV Common Stock M - Exercise D 10,2100 6 000 61 60 234
2021-05-04 2021-05-01 4 Audhya Paul K. KALV Employee Stock Option (right to buy) A - Award D 24,97 100 000 100 000
2021-04-30 2021-04-28 4 Smith Michael David KALV Stock Option (right to buy) M - Exercise D 8,39 -10 014 30 096
2021-04-30 2021-04-28 4 Smith Michael David KALV Common Stock S - Sale D 25,7622 -10 014 -258 0
2021-04-30 2021-04-28 4 Smith Michael David KALV Common Stock M - Exercise D 8,3900 10 014 84 10 014
2021-04-29 2021-04-29 4 Maetzel Andreas KALV Employee Stock Option (right to buy) M - Exercise D 16,08 -13 368 7 332
2021-04-29 2021-04-29 4 Maetzel Andreas KALV Employee Stock Option (right to buy) M - Exercise D 8,21 -14 662 6 038
2021-04-29 2021-04-29 4 Maetzel Andreas KALV Employee Stock Option (right to buy) M - Exercise D 7,91 -12 856 0
2021-04-29 2021-04-29 4 Maetzel Andreas KALV Common Stock S - Sale D 25,0352 -40 886 -1 024 0
2021-04-29 2021-04-29 4 Maetzel Andreas KALV Common Stock M - Exercise D 16,0800 13 368 215 40 886
2021-04-29 2021-04-29 4 Maetzel Andreas KALV Common Stock M - Exercise D 8,2100 14 662 120 27 518
2021-04-29 2021-04-29 4 Maetzel Andreas KALV Common Stock M - Exercise D 7,9100 12 856 102 12 856
2021-04-29 2021-04-28 4 Maetzel Andreas KALV Employee Stock Option (right to buy) M - Exercise D 7,91 -36 127 12 856
2021-04-29 2021-04-28 4 Maetzel Andreas KALV Common Stock S - Sale D 25,6500 -507 -13 0
2021-04-29 2021-04-28 4 Maetzel Andreas KALV Common Stock S - Sale D 25,5387 -10 000 -255 507
2021-04-29 2021-04-28 4 Maetzel Andreas KALV Common Stock S - Sale D 25,2522 -15 000 -379 10 507
2021-04-29 2021-04-28 4 Maetzel Andreas KALV Common Stock S - Sale D 25,5000 -10 620 -271 25 507
2021-04-29 2021-04-28 4 Maetzel Andreas KALV Common Stock M - Exercise D 7,9100 36 127 286 36 127
2021-04-29 2021-04-27 4 Maetzel Andreas KALV Employee Stock Option (right to buy) M - Exercise D 7,91 -11 017 48 983
2021-04-29 2021-04-27 4 Maetzel Andreas KALV Common Stock S - Sale D 25,7931 -11 017 -284 0
2021-04-29 2021-04-27 4 Maetzel Andreas KALV Common Stock M - Exercise D 7,9100 11 017 87 11 017
2021-04-05 2021-04-01 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 28,1125 -800 -22 159 420
2021-04-05 2021-04-01 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 27,4812 -8 500 -234 160 220
2021-04-05 2021-04-01 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 26,2229 -700 -18 168 720
2021-03-19 2021-03-18 4 Stuart Nancy KALV Employee Stock Option (Right to Buy) A - Award D 34,27 14 000 14 000
2021-02-25 2021-02-23 4 Yea Christopher KALV Common Stock S - Sale D 31,8660 -500 -16 47 969
2021-02-25 2021-02-23 4 Yea Christopher KALV Common Stock S - Sale D 32,9383 -3 311 -109 48 469
2021-02-25 2021-02-23 4 Yea Christopher KALV Common Stock S - Sale D 33,7445 -10 389 -351 51 780
2021-02-25 2021-02-23 4 Yea Christopher KALV Common Stock S - Sale D 35,3925 -800 -28 62 169
2021-02-25 2021-02-23 4 Palleiko Benjamin L KALV Employee Stock Option (right to buy) M - Exercise D 6,74 -29 642 29 611
2021-02-25 2021-02-23 4 Palleiko Benjamin L KALV Common Stock S - Sale D 31,7741 -1 256 -40 65 000
2021-02-25 2021-02-23 4 Palleiko Benjamin L KALV Common Stock S - Sale D 33,0578 -5 293 -175 66 256
2021-02-25 2021-02-23 4 Palleiko Benjamin L KALV Common Stock S - Sale D 33,7335 -22 093 -745 71 549
2021-02-25 2021-02-23 4 Palleiko Benjamin L KALV Common Stock S - Sale D 35,4044 -1 000 -35 93 642
2021-02-25 2021-02-23 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 6,7400 29 642 200 94 642
2021-02-25 2021-02-23 4 Feener Edward P. KALV Common Stock S - Sale D 31,7303 -800 -25 54 234
2021-02-25 2021-02-23 4 Feener Edward P. KALV Common Stock S - Sale D 32,9738 -5 471 -180 55 034
2021-02-25 2021-02-23 4 Feener Edward P. KALV Common Stock S - Sale D 33,7244 -23 441 -791 60 505
2021-02-25 2021-02-23 4 Feener Edward P. KALV Common Stock S - Sale D 35,1901 -1 288 -45 83 946
2021-02-25 2021-02-23 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 31,8685 -707 -23 169 420
2021-02-25 2021-02-23 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 32,9380 -1 575 -52 170 127
2021-02-25 2021-02-23 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 33,7254 -7 218 -243 171 702
2021-02-25 2021-02-23 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 35,4000 -500 -18 178 920
2021-02-08 2021-02-07 4 Smith Michael David KALV Stock Option (right to buy) A - Award D 10,20 16 500 16 500
2021-02-08 2021-02-07 4 Yea Christopher KALV Stock Option (right to buy) A - Award D 10,20 20 000 20 000
2021-02-08 2021-02-07 4 Yea Christopher KALV Stock Option (right to buy) A - Award D 24,23 31 000 31 000
2021-02-08 2021-02-07 4 Maetzel Andreas KALV Stock Option (right to buy) A - Award D 10,20 10 000 10 000
2021-02-08 2021-02-07 4 Maetzel Andreas KALV Stock Option (right to buy) A - Award D 24,23 10 000 10 000
2021-02-08 2021-02-07 4 Palleiko Benjamin L KALV Stock Option (right to buy) A - Award D 10,20 20 000 20 000
2021-02-08 2021-02-07 4 Palleiko Benjamin L KALV Stock Option (right to buy) A - Award D 24,23 37 500 37 500
2021-02-08 2021-02-07 4 Palleiko Benjamin L KALV Common Stock A - Award D 32 500 65 000
2021-02-08 2021-02-07 4 Feener Edward P. KALV Stock Option (right to buy) A - Award D 10,20 20 000 20 000
2021-02-08 2021-02-07 4 Feener Edward P. KALV Stock Option (right to buy) A - Award D 24,23 22 500 22 500
2021-02-08 2021-02-07 4 Feener Edward P. KALV Common Stock A - Award D 12 500 85 234
2021-02-08 2021-02-07 4 Crockett Thomas Andrew KALV Stock Option (right to buy) A - Award D 10,20 40 000 40 000
2021-02-08 2021-02-07 4 Crockett Thomas Andrew KALV Stock Option (right to buy) A - Award D 24,23 75 000 75 000
2021-01-06 2021-01-04 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 18,8530 -814 -15 185 420
2021-01-06 2021-01-04 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 18,1317 -9 186 -167 186 234
2021-01-06 2020-10-29 4 Crockett Thomas Andrew KALV Common Stock G - Gift D -6 000 179 420
2021-01-04 2020-12-30 4 Palleiko Benjamin L KALV Employee Stock Option (right to buy) M - Exercise D 6,74 -358 59 253
2021-01-04 2020-12-30 4 Palleiko Benjamin L KALV Common Stock S - Sale D 20,0413 -358 -7 32 500
2021-01-04 2020-12-30 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 6,7400 358 2 32 858
2020-12-18 2020-12-16 4 Yea Christopher KALV Stock Option (right to buy) A - Award D 10,20 80 000 80 000
2020-12-18 2020-12-16 4 Smith Michael David KALV Stock Option (right to buy) A - Award D 10,20 25 000 25 000
2020-12-18 2020-12-16 4 Palleiko Benjamin L KALV Stock Option (right to buy) A - Award D 10,20 85 000 85 000
2020-12-18 2020-12-16 4 Maetzel Andreas KALV Stock Option (right to buy) A - Award D 10,20 20 000 20 000
2020-12-18 2020-12-16 4 Feener Edward P. KALV Stock Option (right to buy) A - Award D 10,20 65 000 65 000
2020-12-18 2020-12-16 4 Crockett Thomas Andrew KALV Stock Option (right to buy) A - Award D 10,20 140 000 140 000
2020-11-04 2020-11-02 4 Feener Edward P. KALV Common Stock S - Sale D 17,1353 -6 000 -103 72 734
2020-11-03 2020-10-30 4 CHA ALBERT By Vivo Opportunity Fund, L.P. KALV Common Stock P - Purchase I 17,3359 47 431 822 1 138 179
2020-11-03 2020-10-30 4 CHA ALBERT By Vivo Opportunity Fund, L.P. KALV Common Stock P - Purchase I 17,1681 68 255 1 172 1 090 748
2020-11-02 2020-10-29 4 Yea Christopher KALV Common Stock S - Sale D 17,4788 -5 000 -87 62 969
2020-10-22 2020-10-21 4 Yea Christopher KALV Common Stock S - Sale D 19,0207 -2 544 -48 67 969
2020-10-22 2020-10-21 4 Yea Christopher KALV Common Stock S - Sale D 17,6837 -3 500 -62 70 513
2020-10-22 2020-10-20 4 Yea Christopher KALV Common Stock S - Sale D 18,0133 -2 302 -41 74 013
2020-10-22 2020-10-20 4 Yea Christopher KALV Common Stock S - Sale D 17,2729 -5 640 -97 76 315
2020-10-22 2020-10-21 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 19,0072 -3 693 -70 195 420
2020-10-22 2020-10-21 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 18,5137 -13 052 -242 199 113
2020-10-22 2020-10-21 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 17,4849 -5 800 -101 212 165
2020-10-22 2020-10-20 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 18,0050 -4 776 -86 217 965
2020-10-22 2020-10-20 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 17,2746 -11 218 -194 222 741
2020-10-22 2020-10-21 4 Feener Edward P. KALV Common Stock S - Sale D 18,7487 -5 407 -101 78 734
2020-10-22 2020-10-21 4 Feener Edward P. KALV Common Stock S - Sale D 17,6539 -3 600 -64 84 141
2020-10-22 2020-10-20 4 Feener Edward P. KALV Common Stock S - Sale D 18,0030 -2 300 -41 87 741
2020-10-22 2020-10-20 4 Feener Edward P. KALV Common Stock S - Sale D 17,2649 -5 600 -97 90 041
2020-10-20 2020-10-16 4 Yea Christopher KALV Common Stock S - Sale D 17,0014 -914 -16 81 955
2020-10-20 2020-10-16 4 Feener Edward P. KALV Common Stock S - Sale D 17,0000 -993 -17 95 641
2020-10-20 2020-10-16 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 17,0056 -1 261 -21 236 959
2020-10-20 2020-04-29 4 Crockett Thomas Andrew KALV Common Stock G - Gift D -3 000 233 959
2020-10-02 2020-10-01 4 SOLAND DANIEL B KALV Director Stock Option (right to buy) A - Award D 12,88 7 000 7 000
2020-10-02 2020-10-01 4 SOLAND DANIEL B KALV Director Stock Option (right to buy) A - Award D 12,88 7 000 7 000
2020-10-02 2020-10-01 4 Unkart Edward W KALV Director Stock Option (right to buy) A - Award D 12,88 7 000 7 000
2020-10-02 2020-10-01 4 Edwards Martin KALV Director Stock Option (right to buy) A - Award D 12,88 7 000 7 000
2020-10-02 2020-10-01 4 CHA ALBERT KALV Director Stock Option (right to buy) A - Award D 12,88 7 000 7 000
2020-10-02 2020-10-01 4 ORONSKY ARNOLD L KALV Director Stock Option (right to buy) A - Award D 12,88 7 000 7 000
2020-10-02 2020-10-01 4 Pereira Brian JG KALV Director Stock Option (right to buy) A - Award D 12,88 7 000 7 000
2020-02-07 2020-02-05 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 17,0500 -200 -3 238 220
2020-02-07 2020-02-05 4 Feener Edward P. KALV Common Stock S - Sale D 17,1100 -100 -2 96 634
2020-02-07 2020-02-05 4 Yea Christopher KALV Common Stock S - Sale D 17,1000 -100 -2 82 869
2019-12-26 2019-12-20 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 17,0219 -2 300 -39 238 420
2019-12-26 2019-12-20 4 Yea Christopher KALV Employee Stock Option (Right to Buy) M - Exercise D 0,00 -2 646 87 390
2019-12-26 2019-12-20 4 Yea Christopher KALV Common Stock S - Sale D 17,0163 -2 646 -45 82 969
2019-12-26 2019-12-20 4 Yea Christopher KALV Common Stock M - Exercise D 0,0043 2 646 0 85 615
2019-12-16 2019-12-16 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 17,0585 -5 400 -92 240 720
2019-12-16 2019-12-13 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 17,0620 -2 200 -38 246 120
2019-12-16 2019-12-12 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 17,0000 -100 -2 248 320
2019-12-16 2019-12-16 4 Yea Christopher KALV Employee Stock Option (Right to Buy) M - Exercise D 0,00 -3 010 90 036
2019-12-16 2019-12-16 4 Yea Christopher KALV Common Stock S - Sale D 17,0493 -3 010 -51 82 969
2019-12-16 2019-12-16 4 Yea Christopher KALV Common Stock M - Exercise D 0,0043 3 010 0 85 979
2019-12-16 2019-12-13 4 Yea Christopher KALV Employee Stock Option (Right to Buy) M - Exercise D 0,00 -1 500 93 046
2019-12-16 2019-12-13 4 Yea Christopher KALV Common Stock S - Sale D 17,0453 -1 500 -26 82 969
2019-12-16 2019-12-13 4 Yea Christopher KALV Common Stock M - Exercise D 0,0043 1 500 0 84 469
2019-12-16 2019-12-12 4 Yea Christopher KALV Employee Stock Option (Right to Buy) M - Exercise D 0,00 -199 94 546
2019-12-16 2019-12-12 4 Yea Christopher KALV Common Stock S - Sale D 17,0000 -199 -3 82 969
2019-12-16 2019-12-12 4 Yea Christopher KALV Common Stock M - Exercise D 0,0043 199 0 83 168
2019-10-03 2019-10-02 4 Unkart Edward W KALV Director Stock Option (Right to Buy) A - Award D 11,21 11,2100 7 000 78 7 000
2019-10-03 2019-10-02 4 ORONSKY ARNOLD L KALV Director Stock Option (Right to Buy) A - Award D 11,21 7 000 7 000
2019-10-03 2019-10-02 4 CHA ALBERT KALV Director Stock Option (Right to Buy) A - Award D 11,21 7 000 7 000
2019-09-30 2019-09-27 4 SOLAND DANIEL B KALV Common Stock P - Purchase D 11,8686 7 962 94 10 000
2019-09-30 2019-09-26 4 SOLAND DANIEL B KALV Common Stock P - Purchase D 11,9000 2 038 24 2 038
2019-07-30 2019-07-29 4 CHA ALBERT By Vivo Capital Fund IX, L.P. KALV Common Stock P - Purchase I 17,1327 5 137 88 124 566
2019-07-30 2019-07-29 4 CHA ALBERT By Vivo Opportunity Fund, L.P. KALV Common Stock P - Purchase I 17,1327 24 730 424 1 022 493
2019-07-30 2019-07-26 4 CHA ALBERT By Vivo Opportunity Fund, L.P. KALV Common Stock P - Purchase I 16,8315 21 942 369 997 763
2019-07-30 2019-07-26 4 CHA ALBERT By Vivo Capital Fund IX, L.P. KALV Common Stock P - Purchase I 16,8315 4 558 77 119 429
2019-07-24 2019-07-23 4 Feener Edward P. KALV Common Stock S - Sale D 18,6521 -1 900 -35 96 734
2019-07-24 2019-07-22 4 Feener Edward P. KALV Common Stock S - Sale D 18,5743 -1 400 -26 98 634
2019-07-24 2019-07-22 4 Yea Christopher KALV Employee Stock Option (Right to Buy) M - Exercise D 0,00 -7 355 94 745
2019-07-24 2019-07-22 4 Yea Christopher KALV Common Stock S - Sale D 18,3453 -7 355 -135 82 969
2019-07-24 2019-07-22 4 Yea Christopher KALV Common Stock M - Exercise D 0,0043 7 355 0 90 324
2019-07-19 2019-07-19 4 CHA ALBERT By Vivo Opportunity Fund, L.P. KALV Common Stock P - Purchase I 17,8367 49 680 886 975 821
2019-07-19 2019-07-19 4 CHA ALBERT By Vivo Capital Fund IX, L.P. KALV Common Stock P - Purchase I 17,6796 10 320 182 114 871
2019-07-19 2019-07-17 4 CHA ALBERT By Vivo Capital Fund IX, L.P. KALV Common Stock P - Purchase I 16,9273 220 4 104 551
2019-07-19 2019-07-17 4 CHA ALBERT By Vivo Opportunity Fund, L.P. KALV Common Stock P - Purchase I 16,9726 1 060 18 926 141
2019-07-17 2019-07-15 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 17,0407 -10 000 -170 248 510
2019-06-28 3 Edwards Martin KALV No Securities are beneficially owned D 0
2019-06-28 2019-06-26 4 Edwards Martin KALV Employee Stock Option (Right to Buy) A - Award D 20,62 14 000 14 000
2019-05-17 2019-05-15 4 Palleiko Benjamin L KALV Employee Stock Option (Right to Buy) A - Award D 24,23 33 750 33 750
2019-05-17 2019-05-15 4 Feener Edward P. KALV Employee Stock Option (Right to Buy) A - Award D 24,23 20 250 20 250
2019-05-17 2019-05-15 4 Maetzel Andreas KALV Employee Stock Option (Right to Buy) A - Award D 24,23 9 000 9 000
2019-05-17 2019-05-15 4 Yea Christopher KALV Employee Stock Option (Right to Buy) A - Award D 24,23 27 900 27 900
2019-05-17 2019-05-15 4 Crockett Thomas Andrew KALV Employee Stock Option (Right to Buy) A - Award D 24,23 67 500 67 500
2019-04-23 3 SOLAND DANIEL B KALV No Securities are beneficially owned D 0
2019-04-23 2019-04-22 4 SOLAND DANIEL B KALV Director Stock Option (Right to Buy) A - Award D 26,40 14 000 14 000
2019-04-23 2019-04-15 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 25,9233 -300 -8 258 510
2019-04-23 2019-04-15 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 24,7609 -9 700 -240 258 810
2019-04-23 2019-04-22 4 Yea Christopher KALV Employee Stock Option (Right to Buy) M - Exercise D 0,00 -7 355 102 100
2019-04-23 2019-04-22 4 Yea Christopher KALV Common Stock S - Sale D 26,7860 -1 000 -27 82 969
2019-04-23 2019-04-22 4 Yea Christopher KALV Common Stock S - Sale D 25,9235 -6 355 -165 83 969
2019-04-23 2019-04-22 4 Yea Christopher KALV Common Stock M - Exercise D 0,0043 7 355 0 90 324
2019-04-22 2019-04-22 4 Palleiko Benjamin L KALV Employee Stock Option (Right to Buy) M - Exercise D 8,39 -2 000 47 354
2019-04-22 2019-04-22 4 Palleiko Benjamin L KALV Common Stock S - Sale D 25,8015 -2 000 -52 32 500
2019-04-22 2019-04-22 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 8,3900 2 000 17 34 500
2019-04-22 2019-04-18 4 Palleiko Benjamin L KALV Employee Stock Option (Right to Buy) M - Exercise D 6,74 -1 073 59 611
2019-04-22 2019-04-18 4 Palleiko Benjamin L KALV Common Stock S - Sale D 25,5111 -1 073 -27 32 500
2019-04-22 2019-04-18 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 6,7400 1 073 7 33 573
2019-04-18 2019-04-17 4 Feener Edward P. KALV Common Stock S - Sale D 25,3932 -916 -23 100 034
2019-04-18 2019-04-17 4 Feener Edward P. KALV Common Stock S - Sale D 24,7750 -3 084 -76 100 950
2019-04-10 2019-04-10 4 SVLSF IV, LLC KALV Common Stock S - Sale D 29,3952 -374 -11 47 471
2019-04-10 2019-04-10 4 SVLSF IV, LLC KALV Common Stock S - Sale D 29,3952 -13 157 -387 1 672 105
2019-04-10 2019-04-09 4 SVLSF IV, LLC KALV Common Stock S - Sale D 28,5305 -377 -11 47 845
2019-04-10 2019-04-09 4 SVLSF IV, LLC KALV Common Stock S - Sale D 28,5305 -13 292 -379 1 685 262
2019-04-10 2019-04-08 4 SVLSF IV, LLC KALV Common Stock S - Sale D 29,4919 -629 -19 48 222
2019-04-10 2019-04-08 4 SVLSF IV, LLC KALV Common Stock S - Sale D 29,4919 -22 171 -654 1 698 554
2019-04-09 2019-04-05 4 Maetzel Andreas KALV Employee Stock Option (Right to Buy) M - Exercise D 7,91 -5 000 60 000
2019-04-09 2019-04-05 4 Maetzel Andreas KALV Common Stock S - Sale D 30,0022 -5 000 -150 0
2019-04-09 2019-04-05 4 Maetzel Andreas KALV Common Stock M - Exercise D 7,9100 5 000 40 5 000
2019-04-02 2019-04-02 4 SVLSF IV, LLC KALV Common Stock S - Sale D 28,7638 -253 -7 48 851
2019-04-02 2019-04-02 4 SVLSF IV, LLC KALV Common Stock S - Sale D 28,7638 -8 888 -256 1 720 725
2019-04-02 2019-04-01 4 SVLSF IV, LLC KALV Common Stock S - Sale D 27,6582 -1 458 -40 49 104
2019-04-02 2019-04-01 4 SVLSF IV, LLC KALV Common Stock S - Sale D 27,6582 -51 373 -1 421 1 729 613
2019-04-02 2019-03-29 4 SVLSF IV, LLC KALV Common Stock S - Sale D 28,3960 -969 -28 50 562
2019-04-02 2019-03-29 4 SVLSF IV, LLC KALV Common Stock S - Sale D 28,3960 -34 133 -969 1 780 986
2019-03-28 2019-03-28 4 SVLSF IV, LLC KALV Common Stock S - Sale D 27,8010 -1 012 -28 51 531
2019-03-28 2019-03-28 4 SVLSF IV, LLC KALV Common Stock S - Sale D 27,8010 -35 653 -991 1 815 119
2019-03-28 2019-03-27 4 SVLSF IV, LLC KALV Common Stock S - Sale D 29,0592 -1 599 -46 52 543
2019-03-28 2019-03-27 4 SVLSF IV, LLC KALV Common Stock S - Sale D 29,0592 -56 318 -1 637 1 850 772
2019-03-28 2019-03-26 4 SVLSF IV, LLC KALV Common Stock S - Sale D 29,6975 -831 -25 54 142
2019-03-28 2019-03-26 4 SVLSF IV, LLC KALV Common Stock S - Sale D 29,6975 -29 262 -869 1 907 090
2019-03-20 2019-03-18 4 Venrock Healthcare Capital Partners II, L.P. By Funds KALV Common Stock S - Sale I 28,7500 -500 000 -14 375 1 544 112
2019-03-20 2019-03-18 4 SVLSF IV, LLC KALV Common Stock S - Sale D 26,7000 -7 246 -193 54 973
2019-03-20 2019-03-18 4 SVLSF IV, LLC KALV Common Stock S - Sale D 26,7000 -255 224 -6 814 1 936 352
2019-03-15 2019-03-14 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 30,1613 -3 000 -90 268 510
2019-03-06 2019-03-05 4 SVLSF IV, LLC KALV Common Stock S - Sale D 23,0365 -893 -21 62 219
2019-03-06 2019-03-05 4 SVLSF IV, LLC KALV Common Stock S - Sale D 23,0365 -31 439 -724 2 191 576
2019-03-06 2019-03-04 4 SVLSF IV, LLC KALV Common Stock S - Sale D 22,9070 -1 197 -27 63 112
2019-03-06 2019-03-04 4 SVLSF IV, LLC KALV Common Stock S - Sale D 22,9070 -42 181 -966 2 223 015
2019-02-21 2019-02-21 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,6000 -4 764 -98 64 309
2019-02-21 2019-02-21 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,6000 -167 779 -3 456 2 265 196
2019-02-21 2019-02-20 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,0159 -641 -13 69 073
2019-02-21 2019-02-20 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,0159 -22 594 -452 2 432 975
2019-02-21 2019-02-19 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,7328 -508 -11 69 714
2019-02-21 2019-02-19 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,7328 -17 912 -371 2 455 569
2019-02-05 3 Pereira Brian JG KALV No Securities are beneficially owned D 0
2019-02-05 2019-02-01 4 Pereira Brian JG KALV Director Stock Option (Right to Buy) A - Award D 17,95 14 000 14 000
2019-01-29 2019-01-25 4 Yea Christopher KALV Employee Stock Option (Right to Buy) M - Exercise D 0,00 -5 453 109 455
2019-01-29 2019-01-25 4 Yea Christopher KALV Common Stock S - Sale D 17,0576 -5 453 -93 82 969
2019-01-29 2019-01-25 4 Yea Christopher KALV Common Stock M - Exercise D 0,0043 5 453 0 88 422
2019-01-24 2016-11-21 4/A Yea Christopher KALV Employee Stock Option (Right to Buy) A - Award D 0,00 116 810 116 810
2019-01-24 2019-01-23 4 Yea Christopher KALV Employee Stock Option (Right to Buy) M - Exercise D 0,00 -600 114 908
2019-01-24 2019-01-23 4 Yea Christopher KALV Common Stock S - Sale D 17,0083 -600 -10 82 969
2019-01-24 2019-01-23 4 Yea Christopher KALV Common Stock M - Exercise D 0,0043 600 0 83 569
2019-01-24 2019-01-22 4 Yea Christopher KALV Employee Stock Option (Right to Buy) M - Exercise D 0,00 -1 302 115 508
2019-01-24 2019-01-22 4 Yea Christopher KALV Common Stock S - Sale D 17,0038 -1 302 -22 82 969
2019-01-24 2019-01-22 4 Yea Christopher KALV Common Stock M - Exercise D 0,0043 1 302 0 84 271
2019-01-18 2019-01-16 4 Feener Edward P. KALV Common Stock S - Sale D 19,8141 -2 300 -46 104 034
2019-01-18 2019-01-16 4 Feener Edward P. KALV Common Stock S - Sale D 19,1985 -1 700 -33 106 334
2019-01-16 2019-01-14 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 19,8623 -901 -18 271 510
2019-01-16 2019-01-14 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 19,2804 -9 099 -175 272 411
2019-01-07 2019-01-07 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,4120 -72 -1 70 222
2019-01-07 2019-01-07 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,4120 -2 527 -52 2 473 481
2019-01-07 2019-01-03 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,0130 -47 -1 70 294
2019-01-07 2019-01-03 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,0130 -1 653 -33 2 476 008
2019-01-02 2019-01-02 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,0000 -6 -0 70 341
2019-01-02 2019-01-02 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,0000 -194 -4 2 477 661
2019-01-02 2018-12-31 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,0040 -702 -14 70 347
2019-01-02 2018-12-31 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,0040 -24 716 -494 2 477 855
2019-01-02 2018-12-28 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,0270 -103 -2 71 049
2019-01-02 2018-12-28 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,0270 -3 631 -73 2 502 571
2018-12-21 2018-12-19 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,0180 -59 -1 71 152
2018-12-21 2018-12-19 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,0180 -2 077 -42 2 506 202
2018-10-05 2018-10-03 4 ALDRICH RICHARD KALV Director Stock Option (Right to Buy) A - Award D 22,65 7 000 7 000
2018-10-05 2018-10-03 4 CHA ALBERT KALV Director Stock Option (Right to Buy) A - Award D 22,65 7 000 7 000
2018-10-05 2018-10-03 4 ORONSKY ARNOLD L KALV Director Stock Option (Right to Buy) A - Award D 22,65 7 000 7 000
2018-10-05 2018-10-03 4 Unkart Edward W KALV Director Stock Option (Right to Buy) A - Award D 22,65 7 000 7 000
2018-09-20 2018-09-18 4 Maetzel Andreas KALV Employee Stock Option (Right to Buy) A - Award D 16,08 20 700 20 700
2018-09-20 2018-09-18 4 Crockett Thomas Andrew KALV Employee Stock Option (Right to Buy) A - Award D 16,08 150 000 150 000
2018-09-20 2018-09-18 4 Palleiko Benjamin L KALV Employee Stock Option (Right to Buy) A - Award D 16,08 52 600 52 600
2018-09-20 2018-09-18 4 Palleiko Benjamin L KALV Common Stock A - Award D 32 500 32 500
2018-09-20 2018-09-18 4 Yea Christopher KALV Employee Stock Option (Right to Buy) A - Award D 16,08 52 600 52 600
2018-09-20 2018-09-18 4 Feener Edward P. KALV Employee Stock Option (Right to Buy) A - Award D 16,08 52 600 52 600
2018-09-20 2018-09-18 4 Feener Edward P. KALV Common Stock F - Taxes D 17,0500 -2 500 -43 108 034
2018-09-20 2018-09-18 4 Feener Edward P. KALV Common Stock A - Award D 12 500 110 534
2018-09-12 2018-09-10 4 ORONSKY ARNOLD L InterWest Partners IX, L.P. KALV Common Stock P - Purchase I 17,0000 58 824 1 000 388 766
2018-09-12 2018-09-10 4 CHA ALBERT See Footnotes KALV Common Stock P - Purchase I 17,0000 1 058 824 18 000 1 359 149
2018-09-10 3 Shah Nimish P By funds KALV Common Stock I 4 088 224
2018-09-10 3 Shah Nimish P By funds KALV Common Stock I 4 088 224
2018-09-10 3 Shah Nimish P By funds KALV Common Stock I 4 088 224
2018-09-10 3 Shah Nimish P By funds KALV Common Stock I 4 088 224
2018-09-10 3 Shah Nimish P By funds KALV Common Stock I 4 088 224
2018-09-10 3 Shah Nimish P By funds KALV Common Stock I 4 088 224
2018-09-10 3 Shah Nimish P By funds KALV Common Stock I 4 088 224
2018-09-10 3 Shah Nimish P By funds KALV Common Stock I 4 088 224
2018-09-10 3 Shah Nimish P By funds KALV Common Stock I 4 088 224
2018-09-10 3 Shah Nimish P By funds KALV Common Stock I 4 088 224
2018-06-06 2018-06-04 4 Yea Christopher KALV Employee Stock Option (Right to Buy) A - Award D 8,21 53 500 53 500
2018-06-06 2018-06-04 4 Palleiko Benjamin L KALV Employee Stock Option (Right to Buy) A - Award D 8,21 71 700 71 700
2018-06-06 2018-06-04 4 Feener Edward P. KALV Employee Stock Option (Right to Buy) A - Award D 8,21 51 800 51 800
2018-06-06 2018-06-04 4 Maetzel Andreas KALV Employee Stock Option (Right to Buy) A - Award D 8,21 20 700 20 700
2018-06-06 2018-06-04 4 Crockett Thomas Andrew KALV Employee Stock Option (Right to Buy) A - Award D 8,21 130 800 130 800
2017-10-19 2017-10-12 4 ALDRICH RICHARD KALV Common Stock P - Purchase I 8,6131 565 065 4 867 934 484
2017-10-16 2017-10-12 4 Shah Rajeev M. KALV Common Stock P - Purchase I 8,5000 850 000 7 225 1 441 070
2017-10-16 2017-10-12 4 RA CAPITAL MANAGEMENT, LLC KALV Common Stock P - Purchase I 8,5000 850 000 7 225 1 441 070
2017-10-12 2017-10-12 4 Novo A/S KALV Common Stock S - Sale D 8,5000 -1 726 000 -14 671 0
2017-10-12 2017-10-12 4 Novo A/S KALV Common Stock S - Sale D 10,0200 -481 -5 1 726 000
2017-10-12 2017-10-11 4 Novo A/S KALV Common Stock S - Sale D 10,2132 -35 519 -363 1 726 481
2017-10-12 2017-10-10 4 Novo A/S KALV Common Stock S - Sale D 15,3600 -75 123 -1 154 1 762 000
2017-10-12 2017-10-10 4 Novo A/S KALV Common Stock S - Sale D 14,0667 -57 580 -810 1 837 123
2017-10-12 2017-10-10 4 Novo A/S KALV Common Stock S - Sale D 13,3892 -61 044 -817 1 894 703
2017-10-12 2017-10-10 4 Novo A/S KALV Common Stock S - Sale D 12,3246 -165 199 -2 036 1 955 747
2017-10-12 2017-10-10 4 Novo A/S KALV Common Stock S - Sale D 11,1760 -190 981 -2 134 2 120 946
2017-10-12 2017-10-10 4 Novo A/S KALV Common Stock S - Sale D 10,3567 -413 356 -4 281 2 311 927
2017-09-29 2017-09-27 4 RA CAPITAL MANAGEMENT, LLC KALV Director Stock Option (right to buy) A - Award I 6,71 6 000 6 000
2017-09-29 2017-09-27 4 ALDRICH RICHARD KALV Director Stock Option (Right to Buy) A - Award D 6,71 6 000 6 000
2017-09-29 2017-09-27 4 CHA ALBERT KALV Director Stock Option (Right to Buy) A - Award D 6,71 6 000 6 000
2017-09-29 2017-09-27 4 ORONSKY ARNOLD L KALV Director Stock Option (Right to Buy) A - Award D 6,71 6 000 6 000
2017-09-29 2017-09-27 4 Shah Rajeev M. KALV Director Stock Option (Right to Buy) A - Award D 6,71 6 000 6 000
2017-09-29 2017-09-27 4 Unkart Edward W KALV Director Stock Option (Right to Buy) A - Award D 6,71 6 000 6 000
2017-09-29 2017-09-27 4 Resnick Joshua KALV Director Stock Option (Right to Buy) A - Award D 6,71 6 000 6 000
2017-09-18 2017-09-15 4/A Novo A/S KALV Common Stock S - Sale D 7,0045 -140 744 -986 2 725 283
2017-09-18 2017-09-14 4/A Novo A/S KALV Common Stock S - Sale D 8,0500 -10 000 -80 2 866 027
2017-09-18 2017-09-13 4/A Novo A/S KALV Common Stock S - Sale D 8,0160 -25 900 -208 2 876 027
2017-09-15 2017-09-15 4 Novo A/S KALV Common Stock S - Sale D 8,0000 -3 -0 2 725 280
2017-09-15 2017-09-15 4 Novo A/S KALV Common Stock S - Sale D 7,0045 -140 744 -986 2 725 283
2017-09-15 2017-09-14 4 Novo A/S KALV Common Stock S - Sale D 8,0500 -10 000 -80 2 866 027
2017-09-15 2017-09-13 4 Novo A/S KALV Common Stock S - Sale D 8,0160 -25 900 -208 2 876 027
2017-05-26 2017-05-25 4 Yea Christopher KALV Employee Stock Option (Right to Buy) A - Award D 7,07 33 800 33 800
2017-05-26 2017-05-25 4 Palleiko Benjamin L KALV Employee Stock Option (Right to Buy) A - Award D 7,07 33 800 33 800
2017-05-26 2017-05-25 4 Crockett Thomas Andrew KALV Employee Stock Option (Right to Buy) A - Award D 7,07 187 000 187 000
2017-05-26 2017-05-25 4 Feener Edward P. KALV Employee Stock Option (Right to Buy) A - Award D 7,07 33 800 33 800
2017-03-27 2017-03-23 4 ORONSKY ARNOLD L KALV Director Stock Option (Right to Buy) A - Award D 7,88 12 000 12 000
2017-03-27 2017-03-23 4 Resnick Joshua KALV Director Stock Option (Right to Buy) A - Award D 7,88 12 000 12 000
2017-03-27 2017-03-23 4 Shah Rajeev M. KALV Director Stock Option (Right to Buy) A - Award D 7,88 12 000 12 000
2017-03-27 2017-03-23 4 Unkart Edward W KALV Director Stock Option (Right to Buy) A - Award D 7,88 12 000 12 000
2017-03-27 2017-03-23 4 ALDRICH RICHARD KALV Director Stock Option (Right to Buy) A - Award D 7,88 12 000 12 000
2017-03-27 2017-03-23 4 CHA ALBERT KALV Director Stock Option (Right to Buy) A - Award D 7,88 12 000 12 000
2017-03-27 2017-03-23 4 RA CAPITAL MANAGEMENT, LLC KALV Director Stock Option (right to buy) A - Award I 7,88 12 000 12 000
2017-03-09 2017-03-08 4 Maetzel Andreas KALV Employee Stock Option (Right to Buy) A - Award D 7,91 65 000 65 000
2016-12-30 2016-12-29 4 Palleiko Benjamin L KALV Employee Stock Option (Right to Buy) A - Award D 6,74 60 684 60 684
2016-11-30 3 Novo A/S KALV Common Stock D 5 803 854
2016-11-30 3 Novo A/S KALV Common Stock D 5 803 854
2016-11-30 3 Feener Edward P. KALV Common Stock D 196 068
2016-11-30 3 Feener Edward P. KALV Common Stock D 196 068
2016-11-30 2016-11-28 4 Feener Edward P. KALV Employee Stock Option (Right to Buy) A - Award D 10,21 20 055 20 055
2016-11-29 2016-11-21 4 ALDRICH RICHARD By Longwood Fund II LP KALV Common Stock A - Award I 369 419 369 419
2016-11-29 2016-11-21 4 Resnick Joshua By SV Life Sciences Fund IV Strategic Partners, L.P. KALV Common Stock A - Award I 71 211 71 211
2016-11-29 2016-11-21 4 Resnick Joshua By SV Life Sciences Fund IV, L.P. KALV Common Stock A - Award I 2 508 279 2 508 279
2016-11-29 2016-11-21 4 Yea Christopher KALV Employee Stock Option (Right to Buy) A - Award D 0,01 116 810 116 810
2016-11-29 2016-11-21 4 Yea Christopher KALV Common Stock A - Award D 82 969 82 969
2016-11-28 3 ORONSKY ARNOLD L By InterWest Partners IX, LP KALV Common Stock I 659 884
2016-11-28 3 ORONSKY ARNOLD L By InterWest Partners IX, LP KALV Common Stock I 659 884
2016-11-28 2016-11-22 4 Palleiko Benjamin L KALV Employee Stock Option (Right to Buy) A - Award D 8,39 49 354 49 354
2016-11-28 2016-11-21 4 Crockett Thomas Andrew KALV Common Stock A - Award D 281 420 281 420
2016-11-25 2016-11-21 4 SVLSF IV, LLC KALV Common Stock A - Award D 71 211 71 211
2016-11-25 2016-11-21 4 SVLSF IV, LLC KALV Common Stock A - Award D 2 508 279 2 508 279
2016-11-23 2016-11-21 4 RA CAPITAL MANAGEMENT, LLC KALV Common Stock A - Award I 591 070 591 070
2016-11-23 2016-11-21 4 Shah Rajeev M. See Footnote (3) KALV Common Stock A - Award I 591 070 591 070
2016-11-23 2016-11-21 4 Renzi David CBYL Stock Option (Right to Buy) M - Exercise D 7,84 -36 640 0
2016-11-23 2016-11-21 4 Renzi David CBYL Common Stock U - Other D 8,5932 -3 186 -27 0
2016-11-23 2016-11-21 4 Renzi David CBYL Common Stock F - Taxes D 8,5932 -33 454 -287 3 186
2016-11-23 2016-11-21 4 Renzi David CBYL Common Stock M - Exercise D 7,8400 36 640 287 36 640
2016-11-22 2016-11-21 4 Basta Steven L CBYL Stock Option (Right to Buy) M - Exercise D 7,84 1 125 0
2016-11-22 2016-11-21 4 Basta Steven L CBYL Common Stock U - Other D 8,5932 -99 -1 0
2016-11-22 2016-11-21 4 Basta Steven L CBYL Common Stock F - Taxes D 8,5932 -1 026 -9 99
2016-11-22 2016-11-21 4 Basta Steven L CBYL Common Stock M - Exercise D 7,8400 1 125 9 1 125
2016-11-22 2016-11-21 4 Maroney Marcee CBYL Stock Option (Right to Buy) M - Exercise D 7,84 -732 0
2016-11-22 2016-11-21 4 Maroney Marcee CBYL Stock Option (Right to Buy) M - Exercise D 7,84 -1 339 0
2016-11-22 2016-11-21 4 Maroney Marcee CBYL Stock Option (Right to Buy) M - Exercise D 7,84 -2 592 0
2016-11-22 2016-11-21 4 Maroney Marcee CBYL Common Stock U - Other D 8,5932 -409 -4 0
2016-11-22 2016-11-21 4 Maroney Marcee CBYL Common Stock F - Taxes D 8,5932 -4 255 -37 409
2016-11-22 2016-11-21 4 Maroney Marcee CBYL Common Stock M - Exercise D 7,8400 4 664 37 4 664
2016-02-02 2016-02-01 4 Saul David Joseph CBYL Stock Option (Right to Buy) A - Award D 2,47 56 000 56 000
2016-01-05 2016-01-04 4 Gravett David M. CBYL Stock Option (Right to Buy) A - Award D 3,33 100 000 100 000
2016-01-05 2016-01-04 4 Renzi David CBYL Stock Option (Right to Buy) A - Award D 3,33 283 000 283 000
2016-01-05 2016-01-04 4 McKune John CBYL Stock Option (Right to buy) A - Award D 3,33 10 000 10 000
2016-01-05 2016-01-04 4 Ramiya Premchandran CBYL Stock Option (Right to Buy) A - Award D 3,33 60 586 60 586
2016-01-05 2016-01-04 4 Maroney Marcee CBYL Stock Option (Right to Buy) A - Award D 3,33 100 000 100 000
2015-12-31 2015-12-30 4 Renzi David CBYL Stock Option (Right to Buy) M - Exercise D 0,56 -10 000 515 825
2015-12-31 2015-12-30 4 Renzi David CBYL Common Stock S - Sale D 3,7000 -10 000 -37 0
2015-12-31 2015-12-30 4 Renzi David CBYL Common Stock M - Exercise D 0,5600 10 000 6 10 000
2015-11-04 2015-11-02 4 McKune John CBYL Stock Option (Right to Buy) A - Award D 4,01 50 000 50 000
2015-08-05 2015-08-03 4 Gravett David M. CBYL Stock Option (Right to Buy) A - Award D 6,91 47 006 47 006
2015-08-05 2015-08-03 4 Maroney Marcee CBYL Stock Option (Right to Buy) A - Award D 6,91 60 831 60 831
2015-08-05 2015-08-03 4 Basta Steven L CBYL Stock Option (Right to Buy) A - Award D 6,91 15 750 15 750
2015-08-05 2015-08-03 4 Renzi David CBYL Stock Option (Right to Buy) A - Award D 6,91 276 506 276 506
2015-08-05 2015-08-03 4 Ramiya Premchandran CBYL Stock Option (Right to Buy) A - Award D 6,91 165 903 165 903
2015-08-05 2015-08-03 4 Lewis Hayley CBYL Stock Option (Right to Buy) A - Award D 6,91 33 181 33 181
2015-08-05 2015-08-03 4 Zadno Reza CBYL Stock Option (Right to Buy) A - Award D 6,91 15 750 15 750
2015-08-05 2015-08-03 4 Clapper David M CBYL Stock Option (Right to Buy) A - Award D 6,91 29 000 29 000
2015-08-05 2015-08-03 4 Unkart Edward W CBYL Stock Option (Right to Buy) A - Award D 6,91 29 000 29 000
2015-08-05 2015-08-03 4 Katkin Keith CBYL Stock Option (Right to Buy) A - Award D 6,91 29 000 29 000
2015-04-27 2015-04-14 4/A CHA ALBERT CBYL Convertible Promissory Note C - Conversion I -2 230 0
2015-04-27 2015-04-14 4/A CHA ALBERT CBYL Convertible Promissory Note C - Conversion I -304 438 0
2015-04-27 2015-04-14 4/A CHA ALBERT CBYL Convertible Promissory Note C - Conversion I -2 842 0
2015-04-27 2015-04-14 4/A CHA ALBERT CBYL Convertible Promissory Note C - Conversion I -387 960 0
2015-04-27 2015-04-14 4/A CHA ALBERT CBYL Series B Convertible Preferred Stock C - Conversion I -18 140 0
2015-04-27 2015-04-14 4/A CHA ALBERT CBYL Series B Convertible Preferred Stock C - Conversion I -2 476 452 0
2015-04-27 2015-04-14 4/A CHA ALBERT See Footnotes CBYL Common Stock P - Purchase I 5,0000 7 364 37 4 204 562
2015-04-27 2015-04-14 4/A CHA ALBERT See Footnotes CBYL Common Stock P - Purchase I 5,0000 1 005 136 5 026 4 197 198
2015-04-27 2015-04-14 4/A CHA ALBERT See Footnotes CBYL Common Stock C - Conversion I 2 230 3 192 062
2015-04-27 2015-04-14 4/A CHA ALBERT See Footnotes CBYL Common Stock C - Conversion I 304 438 3 189 832
2015-04-27 2015-04-14 4/A CHA ALBERT See Footnotes CBYL Common Stock C - Conversion I 2 842 2 885 394
2015-04-27 2015-04-14 4/A CHA ALBERT See Footnotes CBYL Common Stock C - Conversion I 387 960 2 882 552
2015-04-27 2015-04-14 4/A CHA ALBERT See Footnotes CBYL Common Stock C - Conversion I 18 140 2 494 592
2015-04-27 2015-04-14 4/A CHA ALBERT See Footnotes CBYL Common Stock C - Conversion I 2 476 452 2 476 452
2015-04-27 2015-04-24 4 Zadno Reza CBYL Stock Option (Right to Buy) A - Award D 7,45 6 250 6 250
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC CBYL Convertible Promissory Note C - Conversion I -2 230 0
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC CBYL Convertible Promissory Note C - Conversion I -304 438 0
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC CBYL Convertible Promissory Note C - Conversion I -2 842 0
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC CBYL Convertible Promissory Note C - Conversion I -387 960 0
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC CBYL Series B Convertible Preferred Stock C - Conversion I -18 140 0
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC CBYL Series B Convertible Preferred Stock C - Conversion I -2 476 452 0
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC See Footnotes CBYL Common Stock P - Purchase I 5,0000 7 364 37 4 204 562
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC See Footnotes CBYL Common Stock P - Purchase I 5,0000 1 005 136 5 026 4 197 198
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC See Footnotes CBYL Common Stock C - Conversion I 2 230 3 192 062
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC See Footnotes CBYL Common Stock C - Conversion I 304 438 3 189 832
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC See Footnotes CBYL Common Stock C - Conversion I 2 842 2 885 394
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC See Footnotes CBYL Common Stock C - Conversion I 387 960 2 882 552
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC See Footnotes CBYL Common Stock C - Conversion I 18 140 2 494 592
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC See Footnotes CBYL Common Stock C - Conversion I 2 476 452 2 476 452
2015-04-14 2015-04-14 4 NOHRA GUY P CBYL Convertible Promissory Note C - Conversion I -332 990 0
2015-04-14 2015-04-14 4 NOHRA GUY P CBYL Convertible Promissory Note C - Conversion I -424 346 0
2015-04-14 2015-04-14 4 NOHRA GUY P CBYL Series B Convertible Preferred Stock C - Conversion I -1 981 124 0
2015-04-14 2015-04-14 4 NOHRA GUY P CBYL Series A Convertible Preferred Stock C - Conversion I -727 590 0
2015-04-14 2015-04-14 4 NOHRA GUY P CBYL Common Stock P - Purchase I 5,0000 877 500 4 388 4 343 550
2015-04-14 2015-04-14 4 NOHRA GUY P CBYL Common Stock C - Conversion I 332 990 3 466 050
2015-04-14 2015-04-14 4 NOHRA GUY P CBYL Common Stock C - Conversion I 424 346 3 133 060
2015-04-14 2015-04-14 4 NOHRA GUY P CBYL Common Stock C - Conversion I 1 981 124 2 708 714
2015-04-14 2015-04-14 4 NOHRA GUY P CBYL Common Stock C - Conversion I 727 590 727 590
2015-04-14 2015-04-14 4 ACMP IV LLC CBYL Convertible Promissory Note C - Conversion I -332 990 0
2015-04-14 2015-04-14 4 ACMP IV LLC CBYL Convertible Promissory Note C - Conversion I -424 346 0
2015-04-14 2015-04-14 4 ACMP IV LLC CBYL Series B Convertible Preferred Stock C - Conversion I -1 981 124 0
2015-04-14 2015-04-14 4 ACMP IV LLC CBYL Series A Convertible Preferred Stock C - Conversion I -727 590 0
2015-04-14 2015-04-14 4 ACMP IV LLC CBYL Common Stock P - Purchase I 5,0000 877 500 4 388 4 343 550
2015-04-14 2015-04-14 4 ACMP IV LLC CBYL Common Stock C - Conversion I 332 990 3 466 050
2015-04-14 2015-04-14 4 ACMP IV LLC CBYL Common Stock C - Conversion I 424 346 3 133 060
2015-04-14 2015-04-14 4 ACMP IV LLC CBYL Common Stock C - Conversion I 1 981 124 2 708 714
2015-04-14 2015-04-14 4 ACMP IV LLC CBYL Common Stock C - Conversion I 727 590 727 590
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Convertible Promissory Note C - Conversion I -2 230 0
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Convertible Promissory Note C - Conversion I -304 438 0
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Convertible Promissory Note C - Conversion I -2 842 0
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Convertible Promissory Note C - Conversion I -387 960 0
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Series B Convertible Preferred Stock C - Conversion I -18 142 0
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Series B Convertible Preferred Stock C - Conversion I -2 476 452 0
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Common Stock P - Purchase I 5,0000 7 364 37 4 204 564
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Common Stock P - Purchase I 5,0000 1 005 136 5 026 4 197 200
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Common Stock C - Conversion I 2 230 3 192 064
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Common Stock C - Conversion I 304 438 3 189 834
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Common Stock C - Conversion I 2 842 2 885 396
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Common Stock C - Conversion I 387 960 2 882 554
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Common Stock C - Conversion I 18 142 2 494 594
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Common Stock C - Conversion I 2 476 452 2 476 452
2015-04-14 2015-04-14 4 InterWest Management Partners IX, LLC CBYL Convertible Promissory Note C - Conversion I -365 957 0
2015-04-14 2015-04-14 4 InterWest Management Partners IX, LLC CBYL Convertible Promissory Note C - Conversion I -466 357 0
2015-04-14 2015-04-14 4 InterWest Management Partners IX, LLC CBYL Series B Convertible Preferred Stock C - Conversion I -2 145 351 0
2015-04-14 2015-04-14 4 InterWest Management Partners IX, LLC CBYL Series A Convertible Preferred Stock C - Conversion I -831 531 0
2015-04-14 2015-04-14 4 InterWest Management Partners IX, LLC CBYL Common Stock P - Purchase I 5,0000 810 000 4 050 4 619 196
2015-04-14 2015-04-14 4 InterWest Management Partners IX, LLC CBYL Common Stock C - Conversion I 365 957 3 809 196
2015-04-14 2015-04-14 4 InterWest Management Partners IX, LLC CBYL Common Stock C - Conversion I 466 357 3 443 239
2015-04-14 2015-04-14 4 InterWest Management Partners IX, LLC CBYL Common Stock C - Conversion I 2 145 351 2 976 882
2015-04-14 2015-04-14 4 InterWest Management Partners IX, LLC CBYL Common Stock C - Conversion I 831 531 831 531
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Convertible Promissory Note C - Conversion I -2 230 0
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Convertible Promissory Note C - Conversion I -304 438 0
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Convertible Promissory Note C - Conversion I -2 842 0
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Convertible Promissory Note C - Conversion I -387 960 0
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Series B Convertible Preferred Stock C - Conversion I -18 142 0
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Series B Convertible Preferred Stock C - Conversion I -2 476 452 0
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Common Stock P - Purchase I 5,0000 7 364 37 4 204 564
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Common Stock P - Purchase I 5,0000 1 005 136 5 026 4 197 200
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Common Stock C - Conversion I 2 230 3 192 064
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Common Stock C - Conversion I 304 438 3 189 834
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Common Stock C - Conversion I 2 842 2 885 396
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Common Stock C - Conversion I 387 960 2 882 554
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Common Stock C - Conversion I 18 142 2 494 594
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Common Stock C - Conversion I 2 476 452 2 476 452
P
Achat sur le marché public ou privé d'un titre non dérivé ou dérivé
S
Vente sur le marché public ou privé d'un titre non dérivé ou dérivé
A
Attribution, récompense ou autre acquisition de titres de l'entreprise (comme une option).
C
Conversion d'un produit dérivé
D
Vente ou transfert de titres à l'entreprise
F
Paiement du prix d'exercice ou de la dette fiscale en utilisant une partie des titres reçus de l'entreprise
G
Don de titres par ou à l'initié
K
Swaps d'actions et opérations de couverture similaires
M
Exercice ou conversion d'un titre dérivé reçu de l'entreprise (tel qu'une option)
V
Une transaction déclarée volontairement sur le formulaire 4
J
Autre (accompagnée d'une note de bas de page décrivant la transaction)
Other Listings
DE:4XC1 13,20 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista